Found 562 matching trials
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder PHASE3 Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Show More Location
Multiple Locations
Learn More & Join Trial
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT) N/A Major depressive disorder (MDD) is the most common psychiatric disease worl...
Show More Learn More & Join Trial
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics N/A International Observational Registry on Schizophrenia...
Location
Multiple Locations
Learn More & Join Trial
Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study N/A The aim of this pilot study is to determine the feasibility of implementing...
Show More Location
Trinity Health LIFE, New Jersey
Learn More & Join Trial
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity NA Rates of obesity in patients with schizophrenia-spectrum disorder (SSD)s ha...
Show More Status
Active Not Recruiting
Location
Centre for Addiction and Mental Health
Learn More & Join Trial
Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. NA The aim of the present study is to evaluate the effectiveness of the additi...
Show More Learn More & Join Trial
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) PHASE2 To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine PHASE1 This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect o...
Show More Learn More & Join Trial
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms PHASE2 To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Show More Location
K&S Professional Research Services
Learn More & Join Trial
A RCT Study in Schizophrenia Relapse Prevention NA THE AIM OF THE PROJECT The main aim lies in the prevention of frequent rela...
Show More Location
Prague Psychiatric Center
Learn More & Join Trial